{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T07:11:43Z","timestamp":1769843503168,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Obstet Gynecol India"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s13224-024-01997-3","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T11:04:48Z","timestamp":1720004688000},"page":"78-85","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolic and Inflammatory Profiles Across Infertile PCOS Phenotypes: Implications for Clinical Practice"],"prefix":"10.1007","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8785-9162","authenticated-orcid":false,"given":"Faezeh","family":"Mashhadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9652-1166","authenticated-orcid":false,"given":"Nayere","family":"Khadem Ghaebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3570-3246","authenticated-orcid":false,"given":"Fatemeh","family":"Roudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3202-2709","authenticated-orcid":false,"given":"Mohsen","family":"Nematy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,3]]},"reference":[{"issue":"8","key":"1997_CR1","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.3390\/ijms23084110","volume":"23","author":"D Armanini","year":"2022","unstructured":"Armanini D, Boscaro M, Bordin L, Sabbadin C. Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism. Int J Mol Sci. 2022;23(8):4110.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1997_CR2","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1210\/endrev\/bnac001","volume":"43","author":"M Dapas","year":"2022","unstructured":"Dapas M, Dunaif A. Deconstructing a syndrome: genomic insights into PCOS causal mechanisms and classification. Endocr Rev. 2022;43(6):927\u201365.","journal-title":"Endocr Rev"},{"key":"1997_CR3","doi-asserted-by":"publisher","first-page":"102345","DOI":"10.1016\/j.coph.2022.102345","volume":"68","author":"KA Glendining","year":"2023","unstructured":"Glendining KA, Campbell RE. Recent advances in emerging PCOS therapies. Curr Opin Pharmacol. 2023;68:102345.","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"1997_CR4","doi-asserted-by":"publisher","first-page":"e2147454","DOI":"10.1001\/jamanetworkopen.2021.47454","volume":"5","author":"M Cioana","year":"2022","unstructured":"Cioana M, Deng J, Nadarajah A, et al. Prevalence of polycystic ovary syndrome in patients with pediatric type 2 diabetes: a systematic review and meta-analysis. JAMA Network Open. 2022;5(2):e2147454.","journal-title":"JAMA Network Open."},{"issue":"7","key":"1997_CR5","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/biomedicines10071505","volume":"10","author":"N Gleicher","year":"2022","unstructured":"Gleicher N, Darmon S, Patrizio P, Barad DH. Reconsidering the polycystic ovary syndrome (PCOS). Biomedicines. 2022;10(7):1505.","journal-title":"Biomedicines"},{"issue":"1","key":"1997_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12905-022-01762-6","volume":"22","author":"AN Elasam","year":"2022","unstructured":"Elasam AN, Ahmed MA, Ahmed ABA, et al. The prevalence and phenotypic manifestations of polycystic ovary syndrome (PCOS) among infertile Sudanese women: a cross-sectional study. BMC Womens Health. 2022;22(1):165.","journal-title":"BMC Womens Health"},{"issue":"1","key":"1997_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"BC Fauser","year":"2004","unstructured":"Fauser BC, Chang J, Azziz R, et al. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41\u20137.","journal-title":"Hum Reprod"},{"issue":"4","key":"1997_CR8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/humupd\/dmp008","volume":"15","author":"L Moran","year":"2009","unstructured":"Moran L, Teede H. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod Update. 2009;15(4):477\u201388.","journal-title":"Hum Reprod Update"},{"issue":"2","key":"1997_CR9","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.rbmo.2021.05.008","volume":"43","author":"ALP Dietz de Loos","year":"2021","unstructured":"Dietz de Loos ALP, Jiskoot G, Timman R, Beerthuizen A, Busschbach JJV, Laven JSE. Improvements in PCOS characteristics and phenotype severity during a randomized controlled lifestyle intervention. Reprod BioMed Online. 2021;43(2):298\u2013309.","journal-title":"Reprod BioMed Online"},{"issue":"1","key":"1997_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12902-021-00710-z","volume":"21","author":"FKH Shirazi","year":"2021","unstructured":"Shirazi FKH, Khodamoradi Z, Jeddi M. Insulin resistance and high molecular weight adiponectin in obese and non-obese patients with polycystic ovarian syndrome (PCOS). BMC Endocr Disord. 2021;21(1):45.","journal-title":"BMC Endocr Disord"},{"issue":"3","key":"1997_CR11","first-page":"260","volume":"9","author":"M Gholinezhad","year":"2018","unstructured":"Gholinezhad M, Gholsorkhtabaramiri M, Esmaeilzadeh S, Ghanbarpour A. Insulin resistance and adverse metabolic profile in overweight\/obese and normal weight of young women with polycystic ovary syndrome. Caspian J Intern Med. 2018;9(3):260\u20137.","journal-title":"Caspian J Intern Med"},{"key":"1997_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cca.2019.11.003","volume":"502","author":"X Zeng","year":"2020","unstructured":"Zeng X, Xie Y-j, Liu Y-t, Long S-l, Mo Z-c. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clini Chim Acta. 2020;502:214\u201321.","journal-title":"Clini Chim Acta"},{"issue":"2","key":"1997_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4103\/jhrs.JHRS_2_19","volume":"12","author":"A Satyaraddi","year":"2019","unstructured":"Satyaraddi A, Cherian KE, Kapoor N, et al. Body composition, metabolic characteristics, and insulin resistance in obese and nonobese women with polycystic ovary syndrome. J Hum Reprod Sci. 2019;12(2):78\u201384.","journal-title":"J Hum Reprod Sci"},{"issue":"4","key":"1997_CR14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/cen.14421","volume":"95","author":"TM Barber","year":"2021","unstructured":"Barber TM, Franks S. Obesity and polycystic ovary syndrome. Clin Endocrinol. 2021;95(4):531\u201341.","journal-title":"Clin Endocrinol"},{"issue":"8","key":"1997_CR15","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1055\/s-0043-104531","volume":"125","author":"DV Milutinovi\u0107","year":"2017","unstructured":"Milutinovi\u0107 DV, Nikoli\u0107 M, Veli\u010dkovi\u0107 N, et al. Enhanced Inflammation without impairment of insulin signaling in the visceral adipose tissue of 5\u03b1-dihydrotestosterone-induced animal model of polycystic ovary syndrome. Exp Clin Endocrinol Diabetes. 2017;125(8):522\u20139.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"1997_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1152\/japplphysiol.00209.2017","volume":"123","author":"LS Chow","year":"2017","unstructured":"Chow LS, Mashek DG, Wang Q, Shepherd SO, Goodpaster BH, Dub\u00e9 JJ. Effect of acute physiological free fatty acid elevation in the context of hyperinsulinemia on fiber type-specific IMCL accumulation. J Appl Physiol (1985). 2017;123(1):71\u20138.","journal-title":"J Appl Physiol (1985)"},{"issue":"1","key":"1997_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/bmb\/ldac007","volume":"143","author":"TM Barber","year":"2022","unstructured":"Barber TM. Why are women with polycystic ovary syndrome obese? Br Med Bull. 2022;143(1):4.","journal-title":"Br Med Bull"},{"issue":"1","key":"1997_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/bmb\/ldac007","volume":"143","author":"TM Barber","year":"2022","unstructured":"Barber TM. Why are women with polycystic ovary syndrome obese? Br Med Bull. 2022;143(1):4\u201315.","journal-title":"Br Med Bull"},{"issue":"1","key":"1997_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12902-021-00710-z","volume":"21","author":"FKH Shirazi","year":"2021","unstructured":"Shirazi FKH, Khodamoradi Z, Jeddi M. Insulin resistance and high molecular weight adiponectin in obese and non-obese patients with polycystic ovarian syndrome (PCOS). BMC Endocr Disord. 2021;21(1):1\u20137.","journal-title":"BMC Endocr Disord"},{"key":"1997_CR20","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2021.210310","author":"A Khichar","year":"2021","unstructured":"Khichar A, Gupta S, Mishra S, Meena M. Assessment of inflammatory markers in women with PCOS and their correlation with insulin resistance. Clin Lab. 2021. https:\/\/doi.org\/10.7754\/Clin.Lab.2021.210310.","journal-title":"Clin Lab"},{"issue":"2","key":"1997_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1530\/EC-19-0496","volume":"9","author":"SF de Medeiros","year":"2020","unstructured":"de Medeiros SF, Yamamoto MMW, de Medeiros MAS, Barbosa BB, Soares JM, Baracat EC. Changes in clinical and biochemical characteristics of polycystic ovary syndrome with advancing age. Endocr Connect. 2020;9(2):74\u201389.","journal-title":"Endocr Connect"},{"issue":"7640","key":"1997_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature21363","volume":"542","author":"GS Hotamisligil","year":"2017","unstructured":"Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542(7640):177\u201385.","journal-title":"Nature"},{"issue":"7372","key":"1997_CR23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature10600","volume":"479","author":"DJ Baker","year":"2011","unstructured":"Baker DJ, Wijshake T, Tchkonia T, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011;479(7372):232\u20136.","journal-title":"Nature"},{"issue":"20","key":"1997_CR24","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1001\/archinte.167.20.2249","volume":"167","author":"M Maggio","year":"2007","unstructured":"Maggio M, Lauretani F, Ceda GP, et al. Relationship between low levels of anabolic hormones and 6-year mortality in older men: the aging in the Chianti area (InCHIANTI) study. Arch Intern Med. 2007;167(20):2249\u201354.","journal-title":"Arch Intern Med"},{"key":"1997_CR25","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.2147\/DMSO.S245742","volume":"13","author":"F Saheb Sharif-Askari","year":"2020","unstructured":"Saheb Sharif-Askari F, Saheb Sharif-Askari N, Halwani R, Abusnana S, Hamoudi R, Sulaiman N. Low vitamin D serum level is associated with hdl-c dyslipidemia and increased serum thrombomodulin levels of insulin-resistant individuals. Diabetes, Metab Syndr Obes. 2020;13:1599\u2013607.","journal-title":"Diabetes, Metab Syndr Obes"},{"issue":"1","key":"1997_CR26","doi-asserted-by":"publisher","first-page":"6129","DOI":"10.1038\/s41598-019-42700-1","volume":"9","author":"Y-R Cho","year":"2019","unstructured":"Cho Y-R, Ann SH, Won K-B, et al. Association between insulin resistance, hyperglycemia, and coronary artery disease according to the presence of diabetes. Sci Rep. 2019;9(1):6129.","journal-title":"Sci Rep"},{"issue":"1","key":"1997_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12944-020-01410-8","volume":"19","author":"A Kheirollahi","year":"2020","unstructured":"Kheirollahi A, Teimouri M, Karimi M, et al. Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women. Lipids Health Dis. 2020;19(1):235.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"1997_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-020-01410-8","volume":"19","author":"A Kheirollahi","year":"2020","unstructured":"Kheirollahi A, Teimouri M, Karimi M, et al. Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women. Lipids Health Dis. 2020;19(1):1\u20139.","journal-title":"Lipids Health Dis"},{"key":"1997_CR29","doi-asserted-by":"publisher","DOI":"10.4103\/jnsbm.JNSBM_193_20","author":"K Sowndarya","year":"2021","unstructured":"Sowndarya K, Joseph JA, Shenoy A, Hegde A. Evaluation of triglyceride\/high-density lipoprotein ratio as a surrogate marker for insulin resistance in healthy young males. J Nat Sci Biol Med. 2021. https:\/\/doi.org\/10.4103\/jnsbm.JNSBM_193_20.","journal-title":"J Nat Sci Biol Med"},{"issue":"1","key":"1997_CR30","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13098-023-01155-1","volume":"15","author":"K Li","year":"2023","unstructured":"Li K, Hu L, Li X, et al. Effect of C-reactive protein deficiency on insulin resistance reversal in rats with polycystic ovary syndrome through augmented leptin action. Diabetol Metab Syndr. 2023;15(1):180.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"1997_CR31","doi-asserted-by":"publisher","first-page":"18417","DOI":"10.1038\/s41598-020-75390-1","volume":"10","author":"GR Kim","year":"2020","unstructured":"Kim GR, Choi D-W, Nam CM, Jang S-I, Park E-C. Synergistic association of high-sensitivity C-reactive protein and body mass index with insulin resistance in non-diabetic adults. Sci Rep. 2020;10(1):18417.","journal-title":"Sci Rep"},{"issue":"7","key":"1997_CR32","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.3390\/ijms22073789","volume":"22","author":"E Rudnicka","year":"2021","unstructured":"Rudnicka E, Suchta K, Grymowicz M, et al. Chronic Low Grade Inflammation in Pathogenesis of PCOS. Int J Mol Sci. 2021;22(7):3789.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1997_CR33","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/MEG.0000000000002215","volume":"34","author":"A Visaria","year":"2022","unstructured":"Visaria A, Pai S, Cheung M, Ahlawat S. Association between aspartate aminotransferase-to-alanine aminotransferase ratio and insulin resistance among US adults. Eur J Gastroenterol Hepatol. 2022;34(3):316\u201323.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"1997_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161304","volume":"11","author":"D Yadav","year":"2016","unstructured":"Yadav D, Choi E, Ahn SV, et al. Incremental predictive value of serum AST-to-ALT ratio for incident metabolic syndrome: the ARIRANG Study. PLoS ONE. 2016;11(8): e0161304.","journal-title":"PLoS ONE"},{"key":"1997_CR35","doi-asserted-by":"publisher","first-page":"8373","DOI":"10.2147\/IJGM.S341790","volume":"14","author":"H Niu","year":"2021","unstructured":"Niu H, Zhou Y. Nonlinear relationship between AST-to-ALT ratio and the incidence of type 2 diabetes mellitus: a follow-up study. Int J Gen Med. 2021;14:8373\u201382.","journal-title":"Int J Gen Med"},{"key":"1997_CR36","doi-asserted-by":"publisher","first-page":"8373","DOI":"10.2147\/IJGM.S341790","volume":"14","author":"H Niu","year":"2021","unstructured":"Niu H, Zhou Y. Nonlinear relationship between AST-to-ALT ratio and the incidence of type 2 diabetes mellitus: a follow-up study. Int J Gen Med. 2021;14:8373\u201382.","journal-title":"Int J Gen Med"},{"key":"1997_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1041616","author":"C Cao","year":"2022","unstructured":"Cao C, Zhang X, Yuan J, et al. Nonlinear relationship between aspartate aminotransferase to alanine aminotransferase ratio and the risk of prediabetes: a retrospective study based on Chinese adults. Front Endocrinol. 2022. https:\/\/doi.org\/10.3389\/fendo.2022.1041616.","journal-title":"Front Endocrinol"},{"issue":"2","key":"1997_CR38","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3390\/antiox10020270","volume":"10","author":"L Rinaldi","year":"2021","unstructured":"Rinaldi L, Pafundi PC, Galiero R, et al. Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome. a narrative review. Antioxidants. 2021;10(2):270.","journal-title":"Antioxidants"},{"issue":"5","key":"1997_CR39","doi-asserted-by":"publisher","first-page":"287","DOI":"10.37349\/emed.2020.00019","volume":"1","author":"C Acierno","year":"2020","unstructured":"Acierno C, Caturano A, Pafundi PC, Nevola R, Adinolfi LE, Sasso FC. Nonalcoholic fatty liver disease and type 2 diabetes: Pathophysiological mechanisms shared between the two faces of the same coin. Explor Med. 2020;1(5):287\u2013306.","journal-title":"Explor Med"},{"key":"1997_CR40","volume-title":"StatPearls [Internet]","author":"S Swarup","year":"2022","unstructured":"Swarup S, Goyal A, Grigorova Y, Zeltser R. Metabolic syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022."}],"container-title":["The Journal of Obstetrics and Gynecology of India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13224-024-01997-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13224-024-01997-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13224-024-01997-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T03:31:29Z","timestamp":1747452689000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13224-024-01997-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,3]]},"references-count":40,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1997"],"URL":"https:\/\/doi.org\/10.1007\/s13224-024-01997-3","relation":{},"ISSN":["0971-9202","0975-6434"],"issn-type":[{"value":"0971-9202","type":"print"},{"value":"0975-6434","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,3]]},"assertion":[{"value":"24 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were in accordance with the 1964 Helsinki Declaration and its later amendments. The study was approved by the Ethics Committee of Mashhad University of Medical Sciences (ID\u2009=\u20094020097; IR.MUMS.REC. 1402.191). Each participant\u2019s agreement was explained individually, and written consent was obtained from those who agreed to participate in the study. The Human Research Ethics Committee of Mashhad University of Medical Sciences (MUMS) approved the study protocol (ID\u2009=\u20094020097). Informed written consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}